Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Metformin Hydrochloride: Reliable Cell Assays
2026-08-27
Learn how Metformin Hydrochloride (Metformin HCl), SKU B1970, can be incorporated into reproducible cell viability, proliferation, and metabolism-modulation workflows. This scenario-based guide addresses assay interference, solvent compatibility, dose optimization, endpoint interpretation, and practical product selection.
-
Etoposide (VP-16): From DNA Breaks to Translation
2026-08-27
Etoposide is more than a cytotoxic control: it is a mechanistic probe for topoisomerase II–linked DNA damage, apoptosis, and translational exposure risk. This article connects DNA damage assay design with barrier-model evidence and practical development strategy.
-
Z-DEVD-FMK for Apoptosis Assays and Neuroprotection
2026-08-26
Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor that can help distinguish apoptotic execution from overlapping calpain-driven proteolysis. This guide translates its use into practical apoptosis assay, melanoma, neuronal injury, and traumatic brain injury neuroprotection workflows while emphasizing controls, pathway limits, and troubleshooting.
-
p38α Inhibitors Tune Kinase Dephosphorylation
2026-08-26
A bioRxiv study shows that some kinase inhibitors do more than block p38α catalytic activity: they also expose the activation-loop phospho-threonine to the WIP1 phosphatase. Structural and biochemical evidence supports a dual-action mechanism in which inhibitor-stabilized conformations accelerate p38α dephosphorylation, suggesting a route toward more selective kinase control.
-
Bafilomycin A1 in Mitophagy Assay Design
2026-08-25
Bafilomycin A1 is a reversible V-ATPase inhibitor that helps distinguish mitophagy initiation from lysosomal degradation. This guide connects its use in intracellular pH regulation and lysosomal assays with mechanistic insights from Burkholderia pseudomallei infection research.
-
Caspase-3 Colorimetric Assay Kit: Workflow Guide
2026-08-25
The Caspase-3 Colorimetric Assay Kit measures DEVD-dependent caspase-3 activity by detecting p-nitroaniline released from the DEVD-pNA substrate. It is suitable for comparative apoptosis studies and caspase activity measurement in biological lysates, but it should not be used alone to prove apoptosis, define upstream pathway activation, or support a clinical diagnosis.
-
HBTU Workflows for Bioluminescent Peptide Probes
2026-08-24
HBTU streamlines the solid-phase synthesis of reporter-bearing peptides, including constructs designed for immunoproteasome activity assays. This guide connects coupling chemistry with plate-reader implementation, emphasizing practical parameter selection, reproducibility, and troubleshooting rather than unsupported translational claims.
-
HyperScript RT SuperMix for qPCR Workflow
2026-08-24
Build a reproducible two-step qRT-PCR workflow for lncRNA, mRNA, and challenging RNA samples using a thermally stable reverse transcriptase and balanced primer blend. The approach translates the IPCRL1 myocardial ischemia/reperfusion study into practical cDNA synthesis, assay controls, and troubleshooting decisions for low-input gene expression analysis.
-
D-Luciferin Sodium Salt for CAR-M Imaging
2026-08-23
D-Luciferin sodium salt converts firefly luciferase activity into a dynamic readout for CAR macrophage research. This article explains how to interpret ATP-dependent light signals alongside tumor burden, cellular energy metabolism, and immune-state data.
-
Rocilinostat (ACY-1215) Research Workflows
2026-08-22
Rocilinostat (ACY-1215) enables selective HDAC6 perturbation for α-tubulin acetylation, multiple myeloma viability, and combination-response studies. This workflow also shows how to extend HDAC6-focused assays into exploratory primary-cilia research without overstating the SMPD4 evidence.
-
Enzymatic Isolation Shapes Colorectal Cancer Organoids
2026-08-22
This study systematically compares TrypLE, Trypsin–EDTA, Collagenase, and Hyaluronidase for establishing patient-derived colorectal cancer organoids. Its key finding is that Collagenase and Hyaluronidase generally outperform the protease-based approaches for tissue dissociation, stem-cell marker recovery, and organoid expansion, while TrypLE and Trypsin–EDTA better preserve viability but release fewer cells.
-
Latrunculin A for Mechanobiology Assay Design
2026-08-21
Latrunculin A provides a reversible inhibitor of actin assembly for separating cytoskeletal execution from upstream mechanical sensing. This article develops an assay-design framework linking G-actin sequestration to stiffness-dependent axon growth, morphology, and motility measurements.
-
Staurosporine Workflows for Kinase and Apoptosis Studies
2026-08-20
Learn how to use Staurosporine as a controlled kinase-perturbation tool for apoptosis, signaling, motility, and angiogenesis assays. This workflow emphasizes DMSO handling, dose–response design, orthogonal validation, and interpretation of metastasis-related phenotypes.
-
MCC950 sodium in Neuroinflammation Workflows
2026-08-20
MCC950 sodium enables selective NLRP3 inflammasome inhibition across macrophage, neuroinflammation, and autoimmune disease workflows. This guide translates recent astrocyte research into practical assay design, controls, optimization steps, and troubleshooting strategies.
-
Mapping SLC2A5 in PCNSL Tissue with Assay Rigor
2026-08-19
Single-cell evidence identifies SLC2A5-mediated fructose metabolism as a potential vulnerability in primary central nervous system lymphoma. This article translates that mechanistic insight into a disciplined tissue-assay strategy, showing how a Primary Antibody Dilution Buffer can support reproducible immunohistochemistry, immunocytochemistry, and antibody-based in situ hybridization while keeping workflow recommendations distinct from published biological evidence.